Inhibitors of DNA double-strand break repair at the crossroads of cancer therapy and genome editing
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 182, 114195
Abstract
No abstract availableKeywords
Funding Information
- Council of Scientific and Industrial Research, India
- Department of Atomic Energy, Government of India (21/01/2016-BRNS/35074)
- Indo-French Centre for the Promotion of Advanced Research (IFC/5203-4/2015/131)
- Department of Biotechnology, Ministry of Science and Technology, India (BT/PR23078/MED/29/1253/2017, BT/PR27952-INF/22/212/2018)
This publication has 167 references indexed in Scilit:
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome EngineeringCell, 2013
- A novel small molecule RAD51 inactivator overcomes imatinib‐resistance in chronic myeloid leukaemiaEMBO Molecular Medicine, 2013
- Identification of Specific Inhibitors of Human RAD51 Recombinase Using High-Throughput ScreeningACS Chemical Biology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The DNA Damage Response: Making It Safe to Play with KnivesMolecular Cell, 2010
- The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical TargetsMolecular Cell, 2010
- 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA BreaksCell, 2010
- Impaired DNA damage response — An Achilles' heel sensitizing cancer to chemotherapy and radiotherapyEuropean Journal of Pharmacology, 2009
- The DNA-damage response in human biology and diseaseNature, 2009
- Comparison of nonhomologous end joining and homologous recombination in human cellsDNA Repair, 2008